OmniAb (OABI) Non-Current Deffered Revenue (2021 - 2026)

OmniAb (OABI) reported Non-Current Deffered Revenue of $369000.0 for Q1 2026, up 778.57% quarter-over-quarter from $42000.0 in Q2 2025.

OmniAb (OABI) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Non-Current Deffered Revenue data on file, last reported at $369000.0 in Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $369000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $369000.0 (changed N/A YoY), and the FY2024 annual result was $117000.0, down 86.43% from the prior year.
  • Non-Current Deffered Revenue climbed to $369000.0 in Q1 2026 per OABI's latest filing, from $42000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $8.0 million in Q1 2022 and troughed at $41000.0 in Q3 2024.
  • A 5-year average of $2.5 million and a median of $1.4 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue plunged 97.93% in 2024, then sank 41.67% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $4.3 million in 2022, then tumbled by 80.07% to $862000.0 in 2023, then slumped by 86.43% to $117000.0 in 2024, then plunged by 64.1% to $42000.0 in 2025, then jumped by 778.57% to $369000.0 in 2026.
  • Business Quant data shows OABI's Non-Current Deffered Revenue at $369000.0 in Q1 2026, $42000.0 in Q2 2025, and $117000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 369,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 369,000.00
Jun 30, 2025 42,000.00
Dec 31, 2024 117,000.00
Sep 30, 2024 41,000.00
Jun 30, 2024 72,000.00
Mar 31, 2024 279,000.00
Dec 31, 2023 862,000.00
Sep 30, 2023 1.95 Mn
Jun 30, 2023 3.48 Mn
Mar 31, 2023 3.02 Mn
Dec 31, 2022 4.33 Mn
Sep 30, 2022 4.03 Mn
Jun 30, 2022 8.05 Mn
Mar 31, 2022 8.05 Mn
Dec 31, 2021 9.23 Mn
Sep 30, 2021 8.05 Mn